Grants and Contributions:
Title:
E!17003 Ga68-PSMA-11 - Ga-68 Cyclotron Production for Prostate Specific Membrane Antigen (PSMA) Radiopharmaceutical Use in Prostate Cancer
Agreement Number:
981998
Agreement Value:
$591,000.00
Agreement Date:
Oct 1, 2021 - Dec 31, 2022
Description:
EUREKA E!17003 Ga-68-PSMA-11 project with an Israeli partner Isotopia Molecular Imaging Ltd to develop high activity gallium-68 (Ga-68) cyclotron production for Prostate Specific Membrane Antigen (PSMA) radiopharmaceutical use and treatment monitoring in patients with prostate cancer.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burnaby, British Columbia, CA V5A 4N5
Reference Number:
172-2021-2022-Q3-981998
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
838054435
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 92 days.
Amendment Date
Aug 29, 2022
Recipient's Operating Name:
ARTMS
Recipient's Legal Name:
ARTMS Inc.
Federal Riding Name:
Burnaby North--Seymour
Federal Riding Number:
59002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: